P01.097 Subclassification of low-grade gliomas considering TERT promoter mutation and ATRX loss: beyond the 2016 WHO classification

Other literature type English OPEN
Roh, T; Kang, S; Kim, E; Moon, J; Hong, C; Chang, J;
(2018)

BACKGROUND: Grade II glioma is a heterogeneous group of various pathologies. 2016 WHO classification defined subgroups of Grade II gliomas based on isocitrate dehydrogenase (IDH) mutation and 1p/19q codeletion status. However, implications of telomerase reverse transcri... View more
Share - Bookmark